Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-03

FDA Approved: ENTACAPONE — Original Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved an original application for entacapone, a generic COMT inhibitor, to be used in combination with levodopa/carbidopa for Parkinson's disease. The pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entacapone (Entacapone)

Snippet

ORIG AP for ENTACAPONE (ENTACAPONE)